| Literature DB >> 28945938 |
Zhengdong Jiang1, Ke Chen1, Liang Cheng1, Bin Yan1, Weikun Qian1, Junyu Cao1, Jie Li1, Erxi Wu2,3,4, Qingyong Ma1, Wei Yang1.
Abstract
Cancer, a growing health problem worldwide, affects millions of people every year. The overall survival rates of most cancers have been prolonged owing to the efforts of clinicians and scientists. However, some tumors develop resistance to chemoradiotherapeutic agents, and the cancer research community continues to search for effective sensitizers. Resveratrol, a natural polyphenolic phytoalexin, has shown promising effects in inhibiting proliferation and cancer progression in several tumor models. However, its molecular mechanisms and applications in chemotherapy and radiotherapy have yet to be fully determined. In this concise review, we highlight the role and related molecular mechanisms of resveratrol in cancer treatment. In particular, we focus on the role of resveratrol in the tumor microenvironment and the sensitization of cancer cells for chemotherapy and radiotherapy. Resveratrol shows promising efficacies in cancer treatment and may be applied in clinical therapy, but it requires further clinical study.Entities:
Keywords: cancer stem cells; cancer therapy; chemoradiosensitization; resveratrol; tumor microenvironment
Mesh:
Substances:
Year: 2017 PMID: 28945938 DOI: 10.1111/nyas.13466
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN: 0077-8923 Impact factor: 5.691